Détail d'une personne de l'annuaire - fr | Cancéropôle Est, la recherche innovante dans la lutte contre le cancer

Effect of Treatment of Residual Disease After Immunotherapy-Based Combinations on Complete Response Rate of Patients With Metastatic Renal Cell Carcinomas.

Moinard-Butot F, Oriel M, Tricard T, Cazzato RL, Pierard L, Gaillard V, Werle P, Lindner V, Martin S, Schuster C, Roy C, Burgy M, Anthony A, Bigot C, Boudier P, Fritsch A, Olland A, Malouf G, Lang H, Barthélémy P

Clin Genitourin Cancer. 2024 06 5;22(5):102134

[Short-term functional outcomes of laparoscopic robotic-assisted cystectomy (RAC) with ileal conduit urinary diversion (ICUD) for lower urinary tract dysfunction (LUTD): a single-center retrospective study.].

Tomos G, Saussine C, Gaillard V, Lang H, Tricard T

Fr J Urol. 2024 04 16;:102639

Open versus robotic partial nephrectomy in obese patients: a multi-institutional propensity score-matched analysis (UroCCR 43-Robese study).

Beauval JB, Khene ZE, Roumiguié M, Rahota R, Mejean A, Doumerc N, Roupret M, Paparel P, Villers A, Bruyere F, Lebacle C, Nouhaud FX, Champy C, de la Taille A, Lang H, Rizk J, Durand M, Dariane C, Charles T, Boissier R, Long JA, Bigot P, Bensalah K, Bernhard JC

World J Urol. 2024 04 6;42(1):213

Neoadjuvant in Situ and Systemic Immunotherapy with Lymph Node Cryoablation in Resectable Stage III Melanoma Metastasis: a Proof-of-Concept Study.

Braud A, Auloge P, Meyer N, Bouvrais C, Gharbi M, Lang H, Gangi A, Lipsker D

Cardiovasc Intervent Radiol. 2024 04 3;:

MR-Guided Transurethral Ultrasound Ablation (TULSA)-An Emerging Minimally Invasive Treatment Option for Localised Prostate Cancer.

Fung KFK, Cazzato RL, Tricard T, Marini PDE, Bertucci G, Autrusseau PA, Koch G, Weiss J, Garnon J, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2024 03 15;:

Performance of a Region of Interest-based Algorithm in Diagnosing International Society of Urological Pathology Grade Group ≥2 Prostate Cancer on the MRI-FIRST Database-CAD-FIRST Study.

Couchoux T, Jaouen T, Melodelima-Gonindard C, Baseilhac P, Branchu A, Arfi N, Aziza R, Barry Delongchamps N, Bladou F, Bratan F, Brunelle S, Colin P, Correas JM, Cornud F, Descotes JL, Eschwege P, Fiard G, Guillaume B, Grange R, Grenier N, Lang H, Lefèvre F, Malavaud B, Marcelin C, Moldovan PC, Mottet N, Mozer P, Potiron E, Portalez D, Puech P, Renard-Penna R, Roumiguié M, Roy C, Timsit MO, Tricard T, Villers A, Walz J, Debeer S, Mansuy A, Mège-Lechevallier F, Decaussin-Petrucci M, Badet L, Colombel M, Ruffion A, Crouzet S, Rabilloud M, Souchon R, Rouvière O

Eur Urol Oncol. 2024 03 15;:

Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas.

Lu X, Vano YA, Su X, Helleux A, Lindner V, Mouawad R, Spano JP, Rouprêt M, Compérat E, Verkarre V, Sun CM, Bennamoun M, Lang H, Barthelemy P, Cheng W, Xu L, Davidson I, Yan F, Fridman WH, Sautes-Fridman C, Oudard S, Malouf GG

Cell Rep Med. 2023 11 8;:101287

Clinical trial protocol for P-NeLoP: a randomized controlled trial comparing the feasibility and outcomes of robot-assisted partial nephrectomy with low insufflation pressure using AirSeal versus standard insufflation pressure (UroCCR no. 85 study).

Margue G, Bigot P, Ingels A, Roupret M, Waeckel T, Long JA, Pignot G, Bensalah K, Lang H, Olivier J, Bruyere F, Durand M, Beauval JB, Mallet R, Parier B, De La Taille A, Bernhard JC

Trials. 2023 08 19;24(1):545

Prognostic value of PD-L1 and PD-1 expression in upper tract urothelial carcinoma patients.

Campedel L, Compérat E, Cancel-Tassin G, Varinot J, Pfister C, Delcourt C, Gobet F, Roumiguié M, Patard PM, Daniel G, Bigot P, Carrouget J, Eymerit C, Larré S, Léon P, Durlach A, Ruffion A, de Mazancourt ES, Decaussin-Petrucci M, Bessède T, Lebacle C, Ferlicot S, Robert G, Vuong NS, Philip M, Crouzet S, Matillon X, Mège-Lechevallier F, Lang H, Mouracade P, Lindner V, Gougis P, Cussenot O, Rouprêt M, Seisen T

BJU Int. 2023 07 24;:

Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-Cirrhotic Patients. A Multicentric Study of 44 International Expert Centers.

Sousa Da Silva RX, Breuer E, Shankar S, Kawakatsu S, Hołówko W, Coelho JS, Jeddou H, Sugiura T, Ghallab M, Da Silva D, Watanabe G, Botea F, Sakai N, Addeo PF, Tzedakis S, Bartsch F, Balcer K, Lim C, Werey F, López V, Montero LP, Claria RS, Leiting J, Vachharajani N, Hopping E, Torres OJM, Hirano S, Andel D, Hagendoorn J, Psica A, Ravaioli M, Ahn KS, Reese T, Montes LA, Gunasekaran G, Alcázar C, Lim JH, Haroon M, Lu Q, Castaldi A, Orimo T, Moeckli B, Abadía T, Ruffolo L, Hasan JD, Ratti F, Kaufmann EF, de Wilde R, Polak WG, Boggi U, Aldrighetti L, McCormack L, Hernandez-Alejandro R, Serrablo A, Toso C, Taketomi A, Gugenheim J, Dong J, Hanif F, Park JS, Ramia JM, Schwartz M, Ramisch D, De Oliveira M, Oldhafer KJ, Kang KJ, Cescon M, Lodge P, Rinkes IHMB, Noji T, Thomson JE, Goh SK, Chapman WC, Cleary SP, Pekolj J, Regimbeau JM, Scatton O, Truant S, Lang H, Fuks D, Bachellier P, Otsuka M, Popescu I, Hasegawa K, Lesurtel M, Adam R, Cherqui D, Uesaka K, Boudjema K, Marques HP, Grąt M, Petrowsky H, Ebata T, Prachalias A, Robles-Campos R, Clavien PA

Ann Surg. 2023 07 19;:

Late complications and 5 years outcomes of robotic partial nephrectomy in France: prospective assessment in the French Kidney Cancer Research Network (UroCCR 10).

Margue G, Ingels A, Bensalah K, Doumerc N, Vaessen C, Roupret M, Audenet F, Mejean A, Bruyere F, Olivier J, Baumert H, Michel C, Paparel P, Parier B, Sebe P, Long JA, Lang H, Lebret T, Patard JJ, Bernhard JC

World J Urol. 2023 07 6;:

Mesenchymal-like tumor cells and myofibroblastic cancer-associated fibroblasts are associated with progression and immunotherapy response of clear-cell renal cell carcinoma.

Davidson G, Helleux A, Vano YA, Lindner V, Fattori A, Cerciat M, Elaidi RT, Verkarre V, Sun CM, Chevreau C, Bennamoun M, Lang H, Tricard T, Fridman WH, Sautes-Fridman C, Su X, Plassard D, Keime C, Thibault-Carpentier C, Barthélémy P, Oudard SM, Davidson I, Malouf GG

Cancer Res. 2023 06 19;:

A new tumorgraft panel to accelerate precision medicine in prostate cancer.

Béraud C, Bidan N, Lassalle M, Lang H, Lindner V, Krucker C, Masliah-Planchon J, Potiron E, Lluel P, Massfelder T, Allory Y, Misseri Y

Front Oncol. 2023 05 26;13:1130048

SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

Vokshi BH, Davidson G, Tawanaie Pour Sedehi N, Helleux A, Rippinger M, Haller AR, Gantzer J, Thouvenin J, Baltzinger P, Bouarich R, Manriquez V, Zaidi S, Rao P, Msaouel P, Su X, Lang H, Tricard T, Lindner V, Surdez D, Kurtz JE, Bourdeaut F, Tannir NM, Davidson I, Malouf GG

Nat Commun. 2023 05 26;14(1):3034

MRI- Versus CT-Guided Renal Tumor Cryoablation: Is There a Difference?

Cazzato RL, De Marini P, Mayer T, Leclerc L, Leonard-Lorant I, Dalili D, Weiss J, Koch G, Autrusseau PA, Garnon J, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2023 05 24;:

Role of MRI at 1- and 3-Month Follow-up in Predicting the Likelihood of Tumor Recurrence Following Percutaneous Cryoablation of Renal Tumors.

Obellianne J, De Marini P, Cazzato RL, Dalili D, Garnon J, Koch G, Weiss J, Autrusseau PA, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2023 05 16;:

Machine learning approach for prediction of pT3a upstaging and outcomes of localized RCC (UroCCR-15).

Boulenger de Hauteclocque A, Ferrer L, Ambrosetti D, Ricard S, Bigot P, Bensalah K, Henon F, Doumerc N, Méjean A, Verkarre V, Dariane C, Larré S, Champy C, de La Taille A, Bruyère F, Rouprêt M, Paparel P, Droupy S, Fontenil A, Patard JJ, Durand X, Waeckel T, Lang H, Lebâcle C, Guy L, Pignot G, Durand M, Long JA, Charles T, Xylinas E, Boissier R, Yacoub M, Colin T, Bernhard JC

BJU Int. 2023 01 17;:

Oncocytoma on renal mass biopsy: is it still the same histology when surgery is performed? Results from UroCCR-104 study.

Branger N, Bigot P, Pignot G, Lorusso V, Audenet F, Parier B, Doumerc N, Brenier M, Xylinas E, Boissier R, Rouprêt M, Champy C, Nouhaud FX, Lang H, Charles T, Mallet R, Ambrosetti D, Bensalah K, Bernhard JC

World J Urol. 2023 01 12;:

An enhancer demethylator phenotype converged to immune dysfunction and resistance to immune checkpoint inhibitors in clear-cell renal cell carcinomas.

Lu X, Vano Y, Helleux A, Su X, Lindner V, Davidson G, Mouawad R, Spano JP, Roupret M, Elaidi R, Compérat E, Verkarre V, Sun C, Chevreau C, Bennamoun M, Lang H, Tricard T, Cheng W, Xu L, Davidson I, Yan F, Fridman WH, Sautes-Fridman C, Oudard S, Malouf GG

Clin Cancer Res. 2022 11 14;:

Comparison of open and robotic-assisted partial nephrectomy approaches using multicentric data (UroCCR-47 study).

Ingels A, Bensalah K, Beauval JB, Paparel P, Rouprêt M, Lang H, Nouhaud FX, Hénon F, Bruyère F, Audenet F, Lebacle C, Baumert H, Long JA, Tambwe R, Charles T, Xylinas E, Waeckel T, Michiels C, Asselineau J, Bénard A, Margue G, Boissier R, Bigot P, Bernhard JC,

Sci Rep. 2022 11 8;12(1):18981

Positive surgical margin's impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96).

Morrone A, Bentellis I, Bernhard JC, Bensalah K, Champy C, Bruyere F, Doumerc N, Olivier J, Audenet F, Parier B, Brenier M, Long JA, Nouhaud FX, Branger N, Lang H, Charles T, Xylinas E, Waeckel T, Gomez F, Boissier R, Rouget B, Shaikh A, Chevallier D, Ambrosetti D, Durand M

Sci Rep. 2022 10 31;12(1):18342

ASO Visual Abstract: Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-institutional, Prospective Study (UROCCR Study 82).

Tabourin T, Pinar U, Parra J, Vaessen C, Bensalah CK, Audenet F, Bigot P, Champy C, Olivier J, Bruyere F, Doumerc N, Paparel P, Parier B, Nouhaud FX, Durand X, Lang H, Branger N, Long JA, Durand M, Waeckel T, Charles T, Cussenot O, Xylinas E, Boissier R, Tambwe R, Patard JJ, Bernhard JC, Roupret M

Ann Surg Oncol. 2022 08 21;:

Integrated molecular and pharmacological characterization of patient-derived xenografts from bladder and ureteral cancers identifies new potential therapies.

Lang H, Béraud C, Cabel L, Fontugne J, Lassalle M, Krucker C, Dufour F, Groeneveld CS, Dixon V, Meng X, Kamoun A, Chapeaublanc E, De Reynies A, Gamé X, Rischmann P, Bieche I, Masliah-Planchon J, Beaurepere R, Allory Y, Lindner V, Misseri Y, Radvanyi F, Lluel P, Bernard-Pierrot I, Massfelder T

Front Oncol. 2022 08 11;12:930731

Oncological Outcomes of Delayed Nephrectomy After Optimal Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma.

Pignot G, Thiery-Vuillemin A, Albigès L, Walz J, Lang H, Balssa L, Parier B, Geoffrois L, Bensalah K, Schlürmann F, Ladoire S, Bigot P, Borchiellini D, Cassuto O, Thibault C, Ingels A, Saldana V, Roubaud G, Bernhard JC, Gravis G, Barthélémy P

Eur Urol Oncol. 2022 07 16;:

Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82).

Tabourin T, Pinar U, Parra J, Vaessen C, Bensalah CK, Audenet F, Bigot P, Champy C, Olivier J, Bruyere F, Doumerc N, Paparel P, Parier B, Nouhaud FX, Durand X, Lang H, Branger N, Long JA, Durand M, Waeckel T, Charles T, Cussenot O, Xylinas E, Boissier R, Tambwe R, Patard JJ, Bernhard JC, Roupret M

Ann Surg Oncol. 2022 07 3;:

Partial nephrectomy in solitary kidneys: comparison between open surgery and robotic-assisted laparoscopy on perioperative and functional outcomes (UroCCR-54 study).

Benichou Y, Audenet F, Bensalah K, Roupret M, Paparel P, Lebacle C, Bruyère F, Beauval JB, Villers A, Lang H, Durand X, Bigot P, Long JA, Champy C, Lavolle A, Bernhard JC, Alezra E

World J Urol. 2022 06 20;:

Primary care-based follow-up for prostate and kidney cancer survivors: a retrospective monocentric study.

Gaillard V, Tricard T, Rebel S, Schumacher C, Saussine C, Somme G, Lang H

Support Care Cancer. 2022 05 23;:

Impact of the app-based and nurse-led supportive care program AKO@dom on dose intensity of oral-targeted therapies in patients with metastatic renal cell cancer: a multicentric observational retrospective study.

Gaillard V, Lhuillier A, Bigot C, Pierard L, Trensz P, Burgy M, Schuster C, Malouf G, Fritsch A, Lang H, Tricard T, Borchiellini D, Geoffrois L, Barthelemy P

Support Care Cancer. 2022 Apr 29;:

Safety and Oncologic Outcomes of Percutaneous Cryoablation of Renal Cell Carcinoma Recurrences in the Ipsilateral Kidney Following Partial Nephrectomy.

Rossi J, Cazzato RL, de Marini P, Auloge P, Autrusseau PA, Dalili D, Tricard T, Poussot B, Garnon J, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2022 Mar 10;:

Percutaneous Image-Guided Cryoablation of Post-Surgical Renal Cancer Recurrences in the Renal Fossa: A Single-Center Retrospective Analysis.

Bertucci G, Cazzato RL, Barthelemy P, Dalili D, Lang H, Garnon J, Gangi A

Cardiovasc Intervent Radiol. 2022 Jan 3;:

Efficacy of Immune Checkpoint Inhibitors in Upper Tract Urothelial Carcinomas: Current Knowledge and Future Directions.

Thouvenin J, Martínez Chanzá N, Alhalabi O, Lang H, Tannir NM, Barthélémy P, Malouf GG

Cancers (Basel). 2021 Aug 27;13(17):

Postoperative outcomes of elderly patients undergoing partial nephrectomy.

Ingels A, Duc S, Bensalah K, Bigot P, Paparel P, Beauval JB, Salomon L, De La Taille A, Lang H, Nouhaud FX, Batista Da Costa J, Dariane C, Baumert H, Roupret M, Waeckel T, Lebacle C, Long JA, Henon F, Patard JJ, Doumerc N, Mejean A, Videau MN, Bernhard JC

Sci Rep. 2021 Aug 25;11(1):17201

Sunitinib Alone or After Nephrectomy for Patients with Metastatic Renal Cell Carcinoma: Is There Still a Role for Cytoreductive Nephrectomy?

Méjean A, Ravaud A, Thezenas S, Chevreau C, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Oudard S, Laguerre B, Gross-Goupil M, Bernhard JC, Colas S, Albiges L, Lebret T, Treluyer JM, Timsit MO, Escudier B

Eur Urol. 2021 Jun 26;:

Parastomal hernia repair using Pauli's technique (with video).

Liu D, Lang H, Romain B

J Visc Surg. 2021 Jun 3;:

Safety and oncologic efficacy of percutaneous MRI-guided cryoablation of intraparenchymal renal cancers.

De Marini P, Cazzato RL, Garnon J, Dalili D, Leonard-Lorant I, Leclerc L, Autrusseau PA, Auloge P, Weiss J, Tricard T, Lang H, Gangi A

Diagn Interv Imaging. 2021 Apr 27;:

Predictive factors of recurrence after surgery in patients with non-metastatic renal cell carcinoma with venous tumor thrombus (UroCCR-56 Study).

Baboudjian M, Gondran-Tellier B, Khene Z, Bigot P, Mejean A, Lang H, Lebacle C, Doumerc N, Bruyere F, Nouhaud FX, Ouzaid I, Bensalah K, Bernhard JC, Boissier R

World J Urol. 2021 Mar 25;:

Gaillard V, Tricard T, Garnon J, Cazzato R, Gangi A, Lang H

Prog Urol. 2020 Nov;30(13):788

Benichou Y, Bernhard JC, Bensalah K, Roupret M, Dariane C, Paparel P, Lebacle C, Bruyere F, Nouhaud F, Soulie M, Villers A, Lang H, Durand X, Bigot P, Long JA, Champy C

Prog Urol. 2020 Nov;30(13):751-752

Safety and Oncologic Outcomes of Magnetic Resonance Imaging-Guided Cryoablation of Renal Cell Carcinoma: A 10-Year Single-Center Experience.

Cazzato RL, De Marini P, Leonard-Lorant I, Leclerc L, Auloge P, Tricard T, Dalili D, Garnon J, Lang H, Gangi A

Invest Radiol. 2020 Sep 4;:

Diagnostic accuracy and safety of percutaneous MRI-guided biopsy of solid renal masses: single-center results after 4.5 years.

Cazzato RL, De Marini P, Auloge P, Leclerc L, Tricard T, Linder V, Jost M, Ramamurthy N, Lang H, Garnon J, Gangi A

Eur Radiol. 2020 Aug 27;:

Repeat ablative therapy in hereditary or multifocal renal cancer: Functional and oncological outcomes.

Gaillard V, Tricard T, Garnon J, Cazzato RL, Dalili D, Gangi A, Lang H

Urol. Oncol.. 2020 Aug 7;:

Is percutaneous image-guided renal tumour ablation ready for prime time?

Cazzato RL, Garnon J, De Marini P, Auloge P, Koch G, Dalili D, Buy X, Palussiere J, Rao PP, Tricard T, Lang H, Gangi A

Br J Radiol. 2020 Jun 16;:20200284

"Prostate management" under MRI-guidance: 7 years of improvements.

Tricard T, Garnon J, Cazzato RL, Al Hashimi I, Gangi A, Lang H

Transl Cancer Res. 2020 Apr;9(4):2280-2286

[MiT family translocation renal cell carcinomas: Natural history, molecular features and multidisciplinary management].

Herrscher H, Boilève A, Lindner V, Barthélémy P, Hutt É, Pierard L, Kurtz JE, Rioux-Leclercq N, Lang H, Malouf GG

Bull Cancer. 2020 Feb 7;:

Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study.

Felber M, Drouin SJ, Grande P, Vaessen C, Parra J, Barrou B, Matillon X, Crouzet S, Leclerc Q, Rigaud J, Prudhomme T, Doumerc N, Bergerat S, Lang H, Laine C, Robert G, Gobert A, Granger B, Rouprêt M

Urol. Oncol.. 2020 Jan 13;:

Nephrectomy After Complete Response to Immune Checkpoint Inhibitors for Metastatic Renal Cell Carcinoma: A New Surgical Challenge?

Pignot G, Thiery-Vuillemin A, Walz J, Lang H, Werle P, Balssa L, Geoffrois L, Leblanc L, Albigès L, di Nunno V, Bensalah K, Ladoire S, Gravis G, Barthélémy P

Eur. Urol.. 2020 Jan 3;:

Sarcomatoid Dedifferentiation in Renal Cell Carcinoma: From Novel Molecular Insights to New Clinical Opportunities.

Debien V, Thouvenin J, Lindner V, Barthélémy P, Lang H, Flippot R, Malouf GG

Cancers (Basel). 2019 Dec 31;12(1):

[Percutaneous MR-guided prostate cancer cryoablation: Predictive factors and oncologic outcomes].

Gaullier M, Tricard T, Garnon J, Cazzato RL, Munier P, De Marini P, Werle P, Lindner V, Gangi A, Lang H

Prog. Urol.. 2019 Dec 11;:

Percutaneous MR-guided whole-gland prostate cancer cryoablation: safety considerations and oncologic results in 30 consecutive patients.

De Marini P, Cazzato RL, Garnon J, Tricard T, Koch G, Tsoumakidou G, Ramamurthy N, Lang H, Gangi A

Br J Radiol. 2019 03 8;:

Recurrent activating mutations of PPARγ associated with luminal bladder tumors.

Rochel N, Krucker C, Coutos-Thévenot L, Osz J, Zhang R, Guyon E, Zita W, Vanthong S, Hernandez OA, Bourguet M, Badawy KA, Dufour F, Peluso-Iltis C, Heckler-Beji S, Dejaegere A, Kamoun A, de Reyniès A, Neuzillet Y, Rebouissou S, Béraud C, Lang H, Massfelder T, Allory Y, Cianférani S, Stote RH, Radvanyi F, Bernard-Pierrot I

Nat Commun. 2019 Jan 16;10(1):253

Percutaneous MR-guided prostate cancer cryoablation technical updates and literature review.

de Marini P, Cazzato RL, Garnon J, Shaygi B, Koch G, Auloge P, Tricard T, Lang H, Gangi A

BJR Open. 2019 ;1(1):20180043

The drug-resistant pudendal neuralgia management: A systematic review.

Tricard T, Munier P, Story F, Lang H, Saussine C

Neurourol. Urodyn.. 2018 Oct 30;:

Evaluation of axitinib to downstage cT2a renal tumours and allow partial nephrectomy: a phase 2 study.

Lebacle C, Bensalah K, Bernhard JC, Albiges L, Laguerre B, Gross-Goupil M, Baumert H, Lang H, Tricard T, Duclos B, Arnoux A, Piedvache C, Patard JJ, Escudier B

BJU Int.. 2018 Oct 5;:

The Lim1 oncogene as a new therapeutic target for metastatic human renal cell carcinoma.

Hamaidi I, Coquard C, Danilin S, Dormoy V, Béraud C, Rothhut S, Barthelmebs M, Benkirane-Jessel N, Lindner V, Lang H, Massfelder T

Oncogene. 2018 Aug 3;:

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

Méjean A, Ravaud A, Thezenas S, Colas S, Beauval JB, Bensalah K, Geoffrois L, Thiery-Vuillemin A, Cormier L, Lang H, Guy L, Gravis G, Rolland F, Linassier C, Lechevallier E, Beisland C, Aitchison M, Oudard S, Patard JJ, Theodore C, Chevreau C, Laguerre B, Hubert J, Gross-Goupil M, Bernhard JC, Albiges L, Timsit MO, Lebret T, Escudier B

N. Engl. J. Med.. 2018 Jun 3;:

Contemporary assessment of the correlation between Bosniak classification and histological characteristics of surgically removed atypical renal cysts (UroCCR-12 study).

Nouhaud FX, Bernhard JC, Bigot P, Khene ZE, Audenet F, Lang H, Bergerat S, Fraisse G, Grenier N, Cornelis F, Nedelcu C, Béjar S, Fromont-Hankard G, Allory Y, Lindner V, Verkarre V, Daniel L, Yacoub M, Correas JM, Méjean A, Rioux-Leclercq N, Bensalah K

World J Urol. 2018 May 5;:

An FGFR3/MYC positive feedback loop provides new opportunities for targeted therapies in bladder cancers.

Mahe M, Dufour F, Neyret-Kahn H, Moreno-Vega A, Beraud C, Shi M, Hamaidi I, Sanchez-Quiles V, Krucker C, Dorland-Galliot M, Chapeaublanc E, Nicolle R, Lang H, Pouponnot C, Massfelder T, Radvanyi F, Bernard-Pierrot I

EMBO Mol Med. 2018 Apr;10(4):

Trans-rectal Ultrasound-Guided Autologous Blood Injection in the Interprostatorectal Space Prior to Percutaneous MRI-Guided Cryoablation of the Prostate.

Garnon J, Cazzato RL, Koch G, Uri IF, Tsoumakidou G, Caudrelier J, Tricard T, Gangi A, Lang H

Cardiovasc Intervent Radiol. 2018 Apr;41(4):653-659

Safety Considerations and Local Tumor Control Following Percutaneous Image-Guided Cryoablation of T1b Renal Tumors.

Hebbadj S, Cazzato RL, Garnon J, Shaygi B, Buy X, Tsoumakidou G, Lang H, Gangi A

Cardiovasc Intervent Radiol. 2018 Mar;41(3):449-458

[IgG4-related kidney disease: Urologist trap?]

Tricard T, Addeo P, Sauvinet G, Mouracadé P, Lindner V, Le Van Quyen P, Roy C, Lang H, Bachellier P

Prog. Urol.. 2018 03;28(3):135-136

Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.

Korenbaum C, Pierard L, Thiéry A, Story F, Lindner V, Lang H, Kurtz JE, Barthélémy P

Clin Genitourin Cancer. 2017 Dec 28;:

[Ablative therapy in kidney cancer: Indications].

Tricard T, Tsoumakidou G, Lindner V, Garnon J, Albrand G, Cathelineau X, Gangi A, Lang H

Prog. Urol.. 2017 Nov;27(15):926-951

[Percutaneous renal ablation: Pre-, per-, post-interventional evaluation modalities and adapted management].

Garnon J, Tricard T, Cazzato RL, Cathelineau X, Gangi A, Lang H

Prog. Urol.. 2017 Nov;27(15):971-993

[Ablative therapy in kidney cancer: Good practice and perspective].

Gangi A, Cathelineau X, Tricard T, Lang H

Prog. Urol.. 2017 Sep;:

[Ablative therapy in kidney cancer: Oncological, functional, perioperative outcomes and cost].

Mouracade P, Tricard T, Gangi A, Cathelineau X, Lang H

Prog. Urol.. 2017 Sep;:

[Ablative therapy: Urology is underway!]

Cathelineau X, Gangi A, Lang H

Prog. Urol.. 2017 Sep;:

[Evaluation and results of ablative therapies in prostate cancer].

Renard-Penna R, Sanchez-Salas R, Barret E, Cosset JM, de Vergie S, Sapetti J, Ingels A, Gangi A, Lang H, Cathelineau X

Prog. Urol.. 2017 Sep;:

[Indications and limits of ablative therapies in prostate cancer].

Sanchez-Salas R, Barret E, Renard-Penna R, Cosset JM, Dell'Oglio P, Battista J, Gangi A, Lang H, Cathelineau X

Prog. Urol.. 2017 Sep;:

[Management of ablative therapies in prostate cancer].

Barret E, Sanchez-Salas R, Galiano M, Cathala N, Mombet A, Prapotnich D, Rozet F, Gangi A, Lang H, Cathelineau X

Prog. Urol.. 2017 Sep;:

[Image-guided tumor ablation].

Koch G, Cazzato RL, Caudrelier J, Cathelineau X, Lang H, Gangi A

Prog. Urol.. 2017 Aug;:

[Is nephron-sparing surgery relevant for unilateral Wilms tumors?]

Tricard T, Lacreuse I, Louis V, Schneider A, Chaussy Y, Soler L, Moog R, Lang H, Jacqmin D, Becmeur F

Arch Pediatr. 2017 May;:

Primary CIC-DUX4 round cell sarcoma of the kidney: A treatment-refractory tumor with poor outcome.

Bergerat S, Barthelemy P, Mouracade P, Lang H, Saussine C, Lindner V, Jacqmin D

Pathol. Res. Pract.. 2017 Feb;213(2):154-160

Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma.

Bahougne T, Imperiale A, Averous G, Chabrier G, Burnichon N, Gimenez-Roqueplo AP, Dali-Youcef N, Libe R, Baudin E, Roy C, Lang H, Kessler L

Endocr. Relat. Cancer. 2017 Feb;24(2):L7-L11

Prostate cancer diagnosis: Efficacy of a simple electromagnetic MRI-TRUS fusion method to target biopsies.

Jelidi A, Ohana M, Labani A, Alemann G, Lang H, Roy C

Eur J Radiol. 2017 Jan;86:127-134

Adrenal Metastasis of a Poorly Differentiated Adenocarcinoma Mimicking a Pheochromocytoma on 18F-FDOPA PET/CT.

Heimburger C, Averous G, Charlin E, Lang H, Kurtz JE, Imperiale A

Clin Nucl Med. 2016 Sep;41(9):691-2

Establishment of a large panel of patient-derived preclinical models of human renal cell carcinoma.

Lang H, Béraud C, Bethry A, Danilin S, Lindner V, Coquard C, Rothhut S, Massfelder T

Oncotarget. 2016 Sep;7(37):59336-59359

DWI in the Etiologic Diagnosis of Excretory Upper Urinary Tract Lesions: Can It Help in Differentiating Benign From Malignant Tumors? A Retrospective Study of 98 Patients.

Roy C, Labani A, Alemann G, Bierry G, Lang H, Ohana M

AJR Am J Roentgenol. 2016 Jul;207(1):106-13

Fibrous Pseudotumor of the Tunica Vaginalis of the Scrotum: Is there a Typical Ultrasound Pattern?

Ohana M, Lindner V, Labani A, Alemann G, Lang H, Roy C

Ultrasound Int Open. 2016 Mar;2(1):E34-6

Targeting FAK scaffold functions inhibits human renal cell carcinoma growth.

Beraud C, Dormoy V, Danilin S, Lindner V, Bethry A, Hochane M, Coquard C, Barthelmebs M, Jacqmin D, Lang H, Massfelder T

Int J Cancer. 2015 Oct 1;137(7):1549-59

Nephrectomy improves overall survival in patients with metastatic renal cell carcinoma in cases of favorable MSKCC or ECOG prognostic features.

Mathieu R, Pignot G, Ingles A, Crepel M, Bigot P, Bernhard JC, Joly F, Guy L, Ravaud A, Azzouzi AR, Gravis G, Chevreau C, Zini L, Lang H, Pfister C, Lechevallier E, Fais PO, Berger J, Vayleux B, Roupret M, Audenet F, Descazeaud A, Rigaud J, Machiels JP, Staehler M, Salomon L, Ferriere JM, Kleinclauss F, Bensalah K, Patard JJ

Urol Oncol. 2015 Jun 15. pii: S1078-1439(15)00238-0

[Laparoscopic cystectomy and ileal conduit urinary diversion for neurogenic bladders and related conditions. Morbidity and better quality of life.]

Sakhri R, Seigle-Murandi F, Jacqmin D, Lang H, Saussine C

Prog Urol. 2015 Feb 26. pii: S1166-7087(15)00038-X

[Surveillance of stage I testicular seminoma: 20 years oncological results.]

Zores T, Mouracade P, Duclos B, Saussine C, Lang H, Jacqmin D

Prog Urol. 2015 Feb 24. pii: S1166-7087(15)00025-1

Pancreatic metastasis from clear cell renal cell carcinoma: outcome of an aggressive approach.

Benhaim R, Oussoultzoglou E, Saeedi Y, Mouracade P, Bachellier P, Lang H

Urology. 2015 Jan;85(1):135-40

The accuracy of renal tumor biopsy: analysis from a national prospective study.

Bernhard JC, Bigot P, Pignot G, Baumert H, Zini L, Lang H, Crepel M, Monod P, Salomon L, Bellec L, Roupret M, Schneider M, Xylinas E, Paparel P, Bruyere F, Berger J, Ansieau JP, Gimel P, Salome F, Castagnola C, Pfister C, Legraverend JM, Timsit MO, Le Pellec L, Auberget JL, Rolland E, Mallet R, Mejean A, Patard JJ

World J Urol. 2014 Nov 6.

[In Process Citation].

Sakhri R, Seigle-Murandi F, Saussine C, Jacqmin D, Lang H

Prog Urol. 2014 Nov;24(13):830-1

[In Process Citation].

Zores T, Mouracade P, Saeedi Y, Duclos B, Saussine C, Lang H, Jacqmin D

Prog Urol. 2014 Nov;24(13):863

Is there a volume-outcome relationship for partial nephrectomy?

Couapel JP, Bensalah K, Bernhard JC, Pignot G, Zini L, Lang H, Rigaud J, Salomon L, Bellec L, Soulie M, Vaessen C, Roupret M, Jung JL, Mourey E, Bigot P, Bruyere F, Berger J, Ansieau JP, Gimel P, Salome F, Hubert J, Pfister C, Baumert H, Timsit MO, Mejean A, Patard JJ

World J Urol. 2014 Oct;32(5):1323-9

National prospective study on the use of local haemostatic agents during partial nephrectomy.

Lang H, Mouracade P, Gimel P, Bernhard JC, Pignot G, Zini L, Crepel M, Rigaud J, Salomon L, Bellec L, Vaessen C, Roupret M, Jung JL, Mourey E, Martin X, Bigot P, Bruyere F, Berger J, Ansieau JP, Salome F, Hubert J, Pfister C, Trifard F, Gigante M, Baumert H, Mejean A, Patard JJ

BJU Int. 2014 May;113(5b):E56-61

Challenging treatment decision-making in older urologic cancer patients.

Ploussard G, Albrand G, Rozet F, Lang H, Paillaud E, Mongiat-Artus P

World J Urol. 2014 Apr;32(2):299-308

The use of partial nephrectomy: results from a contemporary national prospective multicenter study.

Pignot G, Mejean A, Bernhard JC, Bigot P, Timsit MO, Ferriere JM, Zerbib M, Villers A, Mouracade P, Lang H, Bensalah K, Couapel JP, Rigaud J, Salomon L, Bellec L, Soulie M, Vaessen C, Roupret M, Baumert H, Gimel P, Patard JJ

World J Urol. 2014 Mar 25.

[Postoperative male stress urinary incontinence: outcomes of treatment by I-STOP TOMS(R) transobturator sling].

Ej-Jennane A, Mouracade P, Lang H, Jacqmin D, Saussine C

Prog Urol. 2014 Feb;24(2):127-31

Percutaneous cryoablation for tuberous sclerosis-associated renal angiomyolipoma with neoadjuvant mTOR inhibition.

Krummel T, Garnon J, Lang H, Gangi A, Hannedouche T

BMC Urol. 2014 Sep 25;14:77

Percutaneous renal cryoablation: prospective experience treating 120 consecutive tumors.

Buy X, Lang H, Garnon J, Sauleau E, Roy C, Gangi A

AJR Am J Roentgenol. 2013 Dec;201(6):1353-61

[Laparoscopic approach for artificial urinary sphincter implantation in women with severe urinary stress incontinence].

Trolliet S, Mandron E, Lang H, Jacqmin D, Saussine C

Prog Urol. 2013 Sep;23(10):877-83

Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration.

Bamias A, Tzannis K, Beuselinck B, Oudard S, Escudier B, Diosynopoulos D, Papazisis K, Lang H, Wolter P, de Guillebon E, Stravodimos K, Chrisofos M, Fountzilas G, Elaidi RT, Dimopoulos MA, Bamia C

Br J Cancer. 2013 Jul 23;109(2):332-41

Small solid renal masses: characterization by diffusion-weighted MRI at 3 T.

Agnello F, Roy C, Bazille G, Galia M, Midiri M, Charles T, Lang H

Clin Radiol. 2013 Jun;68(6):e301-8

Comparative sensitivities of functional MRI sequences in detection of local recurrence of prostate carcinoma after radical prostatectomy or external-beam radiotherapy.

Roy C, Foudi F, Charton J, Jung M, Lang H, Saussine C, Jacqmin D

AJR Am J Roentgenol. 2013 Apr;200(4):W361-8

18F-fluorocholine uptake in a case of adrenal incidentaloma: possible diagnostic pitfall or potential tool for adrenocortical tumors characterization?

Imperiale A, Cabral JF, Rust E, Flores-Turk G, Renard C, Hubele F, Detour J, Lang H, Gangi A, Namer IJ

Clin Nucl Med. 2013 Feb;38(2):e83-4

Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.

Dormoy V, Beraud C, Lindner V, Coquard C, Barthelmebs M, Brasse D, Jacqmin D, Lang H, Massfelder T

Carcinogenesis. 2012 Nov;33(11):2084-93

From development to cancer: lessons from the kidney to uncover new therapeutic targets.

Dormoy V, Jacqmin D, Lang H, Massfelder T

Anticancer Res. 2012 Sep;32(9):3609-17.

[Metabolic impact of androgen deprivation therapy for prostate cancer].

Andres E, Eschwege P, Lang H, Moreau JL, Peiffert D, Thiery-Vuillemin A, Kleinclauss F

Prog Urol. 2012 Sep;22 Suppl 2:S39-47

Percutaneous MR-guided cryoablation of prostate cancer: initial experience.

Gangi A, Tsoumakidou G, Abdelli O, Buy X, de Mathelin M, Jacqmin D, Lang H

Eur Radiol. 2012 Aug;22(8):1829-35

Prognostic value of microvascular invasion in predicting the cancer specific survival and risk of metastatic disease in renal cell carcinoma: a multicenter investigation.

Kroeger N, Rampersaud EN, Patard JJ, Klatte T, Birkhauser FD, Shariat SF, Lang H, Rioux-Leclerq N, Remzi M, Zomorodian N, Kabbinavar FF, Belldegrun AS, Pantuck AJ

J Urol. 2012 Feb;187(2):418-23

Pancreatic metastasis of renal cell carcinoma.

Chaudron V, Benhaim R, Renard C, Bachelier P, Lang H, Roy C

. 2011 Sep;51(4):206-15.

[Percutaneous ablation of renal tumors: radiofrequency ablation or cryoablation?].

Buy X, Lang H, Garnon J, Gangi A

J Radiol. 2011 Sep;92(9):774-88

Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.

Neuzillet Y, Tillou X, Mathieu R, Long JA, Gigante M, Paparel P, Poissonnier L, Baumert H, Escudier B, Lang H, Rioux-Leclercq N, Bigot P, Bernhard JC, Albiges L, Bastien L, Petit J, Saint F, Bruyere F, Boutin JM, Brichart N, Karam G, Branchereau J, Ferriere JM, Wallerand H, Barbet S, Elkentaoui H, Hubert J, Feuillu B, Theveniaud PE, Villers A, Zini L, Descazeaux A, Roupret M, Barrou B, Fehri K, Lebret T, Tostain J, Terrier JE, Terrier N, Martin L, Dugardin F, Galliot I, Staerman F, Azemar MD, Irani J, Tisserand B, Timsit MO, Sallusto F, Rischmann P, Guy L, Valeri A, Deruelle C, Azzouzi AR, Chautard D, Mejean A, Salomon L, Rigaud J, Pfister C, Soulie M, Kleinclauss F, Badet L, Patard JJ

Eur Urol. 2011 Aug;60(2):366-73

LIM-class homeobox gene Lim1, a novel oncogene in human renal cell carcinoma.

Dormoy V, Beraud C, Lindner V, Thomas L, Coquard C, Barthelmebs M, Jacqmin D, Lang H, Massfelder T

Oncogene. 2011 Apr 14;30(15):1753-63

Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib.

Beuselinck B, Oudard S, Rixe O, Wolter P, Blesius A, Ayllon J, Elaidi R, Schoffski P, Barrascout E, Morel A, Escudier B, Lang H, Zucman-Rossi J, Medioni J

Ann Oncol. 2011 Apr;22(4):794-800

[Case report of kidney cancer from JOUM 2010].

Neuzillet Y, Guy L, Long JA, Zini L, Chevreau C, Duclos B, Escudier B, Gimel P, Joly F, Lang H, Mejean A, Oudard S, Roumeguere T

Prog Urol. 2011 Mar;21 Suppl 2:S27-33.

[Vaginal prolapse. What dynamic pelvic MRI adds to clinical examination?].

Obringer L, Roy C, Mouracade P, Lang H, Jacqmin D, Saussine C

Prog Urol. 2011 Feb;21(2):93-101

[Recommendations Onco-Urology 2010: Kidney cancer].

Patard JJ, Baumert H, Correas JM, Escudier B, Lang H, Long JA, Neuzillet Y, Paparel P, Poissonnier L, Rioux-Leclercq N, Soulie M

Prog Urol. 2010 Nov;20 Suppl 4:S319-39.

[The role of diffusion 3-Tesla MRI in detecting prostate cancer before needle biopsy: multiparametric study of 111 patients].

Roy C, Pasquali R, Matau A, Bazille G, Lang H

J Radiol. 2010 Nov;91(11 Pt 1):1121-8.

Correlation of introital ultrasound with LUTS after sling surgery.

Mouracade P, El Abiad S, Roy C, Lang H, Jacqmin D, Saussine C

Int Urogynecol J Pelvic Floor Dysfunct. 2010 Oct;21(10):1261-4

Role of the RNA-binding protein HuR in human renal cell carcinoma.

Danilin S, Sourbier C, Thomas L, Lindner V, Rothhut S, Dormoy V, Helwig JJ, Jacqmin D, Lang H, Massfelder T

Carcinogenesis. 2010 Jun;31(6):1018-26

[Current role of lymph node dissection in renal cell carcinoma: review of the literature by the Oncology Committee of the French Association of Urology (CCAFU)].

Paparel P, Long JA, Baumert H, Meyer V, Escudier B, Grenier N, Hetet JF, Rioux-Leclercq N, Lang H, Poissonier L, Soulie M, Patard JJ

Prog Urol. 2010 May;22(6):313-7

Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.

Bensalah K, Pantuck AJ, Rioux-Leclercq N, Thuret R, Montorsi F, Karakiewicz PI, Mottet N, Zini L, Bertini R, Salomon L, Villers A, Soulie M, Bellec L, Rischmann P, De la Taille A, Avakian R, Crepel M, Ferriere JM, Bernhard JC, Dujardin T, Pouliot F, Rigaud J, Pfister C, Albouy B, Guy L, Joniau S, van Poppel H, Lebret T, Culty T, Saint F, Zisman A, Raz O, Lang H, Spie R, Wille A, Roigas J, Aguilera A, Rambeaud B, Martinez Pineiro L, Nativ O, Farfara R, Richard F, Roupret M, Doehn C, Bastian PJ, Muller SC, Tostain J, Belldegrun AS, Patard JJ

Eur Urol. 2010 Mar;57(3):466-71

Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer.

Patard JJ, Escudier B, Paparel P, Neuzillet Y, Long JA, Baumert H, Correas JM, Lang H, Poissonnier L, Rioux-Leclercq N, Soulie M

Prog Urol. 2010 Mar;20 Suppl 1:S11-5

Renal cell carcinoma: which criteria to define antiangiogenic treatment failure? A case report.

Lang H, Lassau N, Thibault F, Delva R, Pignot G

Prog Urol. 2010 Mar;20 Suppl 1:S23-6

[The role of introital ultrasonography in treating low urinary tract symptoms complicating sub-urethral tape placement]

Mouracade P, Ej-Jennane A, Lang H, Jacqmin D, Saussine C

Prog Urol. 2010 Feb;20(2):148-53

[External validation of the University of Los Angeles Integrated Staging System (UISS) in localized renal cell carcinoma: single center study]

Onea C, Mouracade P, Roman H, Wagner B, Saussine C, Jacqmin D, Lang H

Prog Urol. 2010 Jan;20(1):35-9

Conditional survival predictions after nephrectomy for renal cell carcinoma.

Karakiewicz PI, Suardi N, Capitanio U, Isbarn H, Jeldres C, Perrotte P, Sun M, Ficarra V, Zigeuner R, Tostain J, Mejean A, Cindolo L, Pantuck AJ, Belldegrun AS, Zini L, de la Taille A, Chautard D, Descotes JL, Shariat SF, Valeri A, Mulders PF, Lang H, Lechevallier E, Patard JJ

J Urol. 2009 Dec;182(6):2607-12

Survival of patients with nonmetastatic pT3 renal tumours: a matched comparison of laparoscopic vs open radical nephrectomy.

Bensalah K, Salomon L, Lang H, Zini L, Jacqmin D, Manunta A, Crepel M, Ficarra V, Cindolo L, de La Taille A, Karakiewicz P, Patard JJ

BJU Int. 2009 Dec;104(11):1714-7

The sonic hedgehog signaling pathway is reactivated in human renal cell carcinoma and plays orchestral role in tumor growth.

Dormoy V, Danilin S, Lindner V, Thomas L, Rothhut S, Coquard C, Helwig JJ, Jacqmin D, Lang H, Massfelder T

Mol. Cancer. 2009 Dec;8:123

[In situ ablative treatment for renal tumors in 2009]

Lang H

Prog Urol. 2009 Dec;19(12):865-7

Interstitial cystitis: clinical aspects, diagnosis and response to cimetidine

Mouracade P, Ej-Jennane A, Lang H, Jacqmin D, Saussine C

Pelvi-perineologie. 2009 Sep;4(3):184-7

[Clamping modalities during partial nephrectomy: technical aspects and functional consequences. Review by the Comite de cancerologie de l'Association francaise d'urologie (CCAFU)]

Neuzillet Y, Long JA, Paparel P, Baumert H, Correas JM, Escudier B, Lang H, Poissonnier L, Rioux-Leclercq N, Salomon L, Soulie M, Patard JJ

Prog Urol. 2009 Sep;19(8):524-9

Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.

Jeldres C, Patard JJ, Capitanio U, Perrotte P, Suardi N, Crepel M, Ficarra V, Cindolo L, de La Taille A, Tostain J, Pfister C, Albouy B, Colombel M, Mejean A, Lang H, Jacqmin D, Bernhard JC, Ferriere JM, Bensalah K, Karakiewicz PI

Urology. 2009 Jun;73(6):1300-5

Surgical strategy in locally advanced and metastatic renal cell carcinoma

Patard JJ, Culine S, Ravaud A, Lang H

Oncologie. 2009 May;11(5):272-7

von Hippel-Lindau tumor suppressor gene-dependent mRNA stabilization of the survival factor parathyroid hormone-related protein in human renal cell carcinoma by the RNA-binding protein HuR.

Danilin S, Sourbier C, Thomas L, Rothhut S, Lindner V, Helwig JJ, Jacqmin D, Lang H, Massfelder T

Carcinogenesis. 2009 Mar;30(3):387-96

Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.

Wagner B, Patard JJ, Mejean A, Bensalah K, Verhoest G, Zigeuner R, Ficarra V, Tostain J, Mulders P, Chautard D, Descotes JL, de la Taille A, Salomon L, Prayer-Galetti T, Cindolo L, Valeri A, Meyer N, Jacqmin D, Lang H

Eur Urol. 2009 Feb;55(2):452-9

Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.

Capitanio U, Jeldres C, Patard JJ, Perrotte P, Zini L, de La Taille A, Ficarra V, Cindolo L, Bensalah K, Artibani W, Tostain J, Valeri A, Zigeuner R, Mejean A, Descotes JL, Lechevallier E, Mulders PF, Lang H, Jacqmin D, Karakiewicz PI

BJU Int. 2009 Jan;103(1):33-7

[Atypical cysts and cystic tumours of the kidney: histological, radiological and surgical considerations. Conclusions of the AFU 2007 forum]

Long JA, Neuzillet Y, Correas JM, de Fromont M, Lang H, Mejean A, Poissonnier L, Patard JJ, Escudier B, Davin JL

Prog Urol. 2009 Jan;19(1):8-14

Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.

Karakiewicz PI, Jeldres C, Suardi N, Hutterer GC, Perrotte P, Capitanio U, Ficarra V, Cindolo L, de La Taille A, Tostain J, Mulders PF, Salomon L, Zigeuner R, Schips L, Chautard D, Valeri A, Lechevallier E, Descots JL, Lang H, Mejean A, Verhoest G, Patard JJ

Can Urol Assoc J. 2008 Dec;2(6):610-7.

Role of contrast enhanced US in the evaluation of renal tumors

Roy C, Gengler L, Sauer B, Lang H

J Radiol. 2008 Nov;89(11 Pt 1):1735-44.

[Using the intersitital cystitis new diagnostic criteria in daily practice: about 156 patients]

Mouracade P, Lang H, Jacqmin D, Saussine C

Prog Urol. 2008 Nov;18(10):674-7

Novel technique for in situ cold perfusion in laparoscopic partial nephrectomy.

Simon J, Meilinger M, Lang H, Hautmann RE, de Petriconi R

Surg Endosc. 2008 Oct;22(10):2184-9

Transvaginal tape lysis for urinary obstruction after suburethral tape placement. When to do an immediate replacement?

Mouracade P, Lang H, Jacqmin D, Saussine C

Int Urogynecol J Pelvic Floor Dysfunct. 2008 Sep;19(9):1271-4

Kidney cancer management in 2007: news and recommendations

Cornu JN, Roupret M, Lang H, Long JA, Neuzillet Y, Patard JJ, Piechaud T, Correas JM, de Fromont M, Escudier B, Mejean A

Prog Urol. 2008 Jul;18 Suppl 4:S81-7.

Treatment of postoperative mate urinary incontinence by bone-anchored male sling

Mouracade P, Wagner B, Charles T, Lang H, Jacqmin D, Saussine C

Prog Urol. 2008 Jun;18(6):390-4

Accuracy of intermediate dose of furosemide injection to improve multidetector row CT urography.

Roy C, Jeantroux J, Irani FG, Sauer B, Lang H, Saussine C

Eur J Radiol. 2008 May;66(2):253-61

[Can candidates for reimplantation of suburethral sling after sling removal due to chronic obstruction be identified intraoperatively?]

Mouracade P, Lang H, Jacqmin D, Saussine C

Prog Urol. 2008 Apr;18(4):238-44

[What may be the waiting time between the diagnosis and surgical treatment of kidney cancer?]

Neuzillet Y, Correas JM, Escudier B, de Fromont M, Lang H, Long JA, Patard JJ, Poissonnier L, Mejean A

Prog Urol. 2008 Apr;18(4):197-203

Tubeless percutaneous nephrolithotomy: what about replacing the Double-J stent with a ureteral catheter?

Mouracade P, Spie R, Lang H, Jacqmin D, Saussine C

J Endourol. 2008 Feb;22(2):273-5.

Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.

Sourbier C, Danilin S, Lindner V, Steger J, Rothhut S, Meyer N, Jacqmin D, Helwig JJ, Lang H, Massfelder T

Cancer Res. 2007 Dec 15;67(24):11668-76.

[Kidney tumors]

Mejean A, Correas JM, Escudier B, de Fromont M, Lang H, Long JA, Neuzillet Y, Patard JJ, Piechaud T

Prog Urol. 2007 Nov;17(6):1101-44.

Collecting duct renal cell carcinoma: a matched analysis of 41 cases.

Karakiewicz PI, Trinh QD, Rioux-Leclercq N, de la Taille A, Novara G, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Lechevallier E, Coulange C, Valeri A, Descotes JL, Rambeaud JJ, Abbou CC, Lang H, Jacqmin D, Mejean A, Patard JJ

Eur Urol. 2007 Oct;52(4):1140-5

Parathyroid hormone-related protein induces cell survival in human renal cell carcinoma through the PI3K Akt pathway: evidence for a critical role for integrin-linked kinase and nuclear factor kappa B.

Agouni A, Sourbier C, Danilin S, Rothhut S, Lindner V, Jacqmin D, Helwig JJ, Lang H, Massfelder T

Carcinogenesis. 2007 Sep;28(9):1893-901

Unexpected paracrine action of prostate cancer cells harboring a new class of androgen receptor mutation--a new paradigm for cooperation among prostate tumor cells.

Lapouge G, Erdmann E, Marcias G, Jagla M, Monge A, Kessler P, Serra S, Lang H, Jacqmin D, Bergerat JP, Ceraline J

Int J Cancer. 2007 Sep 15;121(6):1238-44.

A new staging system for locally advanced (pT3-4) renal cell carcinoma: a multicenter European study including 2,000 patients.

Ficarra V, Galfano A, Guille F, Schips L, Tostain J, Mejean A, Lang H, Mulders P, De La Taille A, Chautard D, Descotes JL, Cindolo L, Novara G, Rioux-Leclercq N, Zattoni F, Artibani W, Patard JJ

J Urol. 2007 Aug;178(2):418-24; discussion 423-4

Relationship between age at diagnosis and clinicopathologic features of renal cell carcinoma.

Verhoest G, Veillard D, Guille F, De La Taille A, Salomon L, Abbou CC, Valeri A, Lechevallier E, Descotes JL, Lang H, Jacqmin D, Tostain J, Cindolo L, Ficarra V, Artibani W, Schips L, Zigeuner R, Mulders PF, Mejean A, Patard JJ

Eur Urol. 2007 May;51(5):1298-304; discussion 1304-5

Multi-institutional validation of a new renal cancer-specific survival nomogram.

Karakiewicz PI, Briganti A, Chun FK, Trinh QD, Perrotte P, Ficarra V, Cindolo L, De la Taille A, Tostain J, Mulders PF, Salomon L, Zigeuner R, Prayer-Galetti T, Chautard D, Valeri A, Lechevallier E, Descotes JL, Lang H, Mejean A, Patard JJ

J Clin Oncol. 2007 Apr 10;25(11):1316-22.